Azitra (AZTR) Operating Income (2022 - 2026)
Azitra (AZTR) reported Operating Income of -$3.9 million for Q1 2026, down 25.8% on a YoY basis from -$5.3 million in Q1 2025, and down 72.57% quarter-over-quarter from -$2.3 million in Q4 2025.
Azitra (AZTR) Operating Income (2022 - 2026) Analysis & Trends
Azitra has reported Operating Income for 5 years, with the latest figure at -$3.9 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Income fell 25.8% year-over-year to -$3.9 million; the trailing twelve-month figure through Mar 2026 stood at -$11.8 million (down 6.08% YoY), and the FY2025 full-year result was -$11.0 million, changed 0.14% from the prior year.
- Operating Income for Q1 2026 stood at -$3.9 million, down from -$2.3 million in the prior quarter.
- The five-year high for Operating Income was -$1.4 million in Q2 2023, with the low at -$3.9 million in Q1 2026.
- Historically, Operating Income has averaged -$2.5 million across 5 years, with a median of -$2.6 million in 2023.
- Annual changes were most pronounced in 2023 — Operating Income soared 31.64% — and 2024, when it plunged 89.99%.
- Azitra's Operating Income stood at -$2.7 million in 2022, then gained by 8.44% to -$2.5 million in 2023, then advanced by 1.47% to -$2.4 million in 2024, then rose by 7.16% to -$2.3 million in 2025, then tumbled by 72.57% to -$3.9 million in 2026.
- The last three Operating Income figures came in at -$3.9 million (Q1 2026), -$2.3 million (Q4 2025), and -$2.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Azitra | 20,900.00 | 20,900.00 | - | -3.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.90 Mn |
| Dec 31, 2025 | -2.26 Mn |
| Sep 30, 2025 | -2.77 Mn |
| Jun 30, 2025 | -2.87 Mn |
| Mar 31, 2025 | -3.10 Mn |
| Dec 31, 2024 | -2.43 Mn |
| Sep 30, 2024 | -2.93 Mn |
| Jun 30, 2024 | -2.66 Mn |
| Mar 31, 2024 | -2.96 Mn |
| Dec 31, 2023 | -2.47 Mn |
| Sep 30, 2023 | -1.99 Mn |
| Jun 30, 2023 | -1.43 Mn |
| Mar 31, 2023 | -1.56 Mn |
| Dec 31, 2022 | -2.70 Mn |
| Sep 30, 2022 | -2.37 Mn |
| Jun 30, 2022 | -2.09 Mn |